$59.42 (3.76%)

Volume: 1.541M

Closed: Dec 02, 2022

Hollow Logo Score: 0.000

Halozyme Therapeutics Stock Forecast

$59.42 (3.76%)

Volume: 1.541M

Closed: Dec 02, 2022

Score Hollow Logo 0.000

Halozyme Therapeutics Stock Earnings Report NASDAQ:HALO

Current P/E ratio: 16.55 | Price (Dec 02, 2022, EOD): $59.42 (Find current average P/E ratios for all sectors below)

HALO Upcoming Earnings

Currently no data available.

HALO Analysts Price Targets

Currently no data available.

About Halozyme Therapeutics

Halozyme TherapeuticsHalozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.

Last 3 Quarters for HALO Premium

Below you can see how HALO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Earnings Report Demo

What Is an Earnings Report?

An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content

Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports

Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.

Average Sector P/E ratio

Is your stock priced above or below the average P/E ratio?

A higher P/E ratio shows that investors are willing to pay a higher share price today because of growth expectations in the future. For example, a company with a current P/E of 25, trades at 25 times today's earnings.

Name Number of firms Average PE
Advertising 47 20
Aerospace/Defense 77 35
Air Transport 18 15
Apparel 51 26
Auto & Truck 13 15
Auto Parts 46 16
Bank (Money Center) 7 11
Banks (Regional) 611 17
Beverage (Alcoholic) 21 38
Beverage (Soft) 34 35
Broadcasting 27 14
Brokerage & Investment Banking 39 14
Building Materials 42 23
Business & Consumer Services 165 32
Cable TV 14 156
Chemical (Basic) 43 14
Chemical (Diversified) 6 10
Chemical (Specialty) 94 25
Coal & Related Energy 22 7
Computer Services 106 27
Computers/Peripherals 48 24
Construction Supplies 44 22
Diversified 23 45
Drugs (Biotechnology) 503 77
Drugs (Pharmaceutical) 267 22
Education 35 21
Electrical Equipment 113 28
Electronics (Consumer & Office) 20 18
Electronics (General) 153 49
Engineering/Construction 54 24
Entertainment 107 150
Environmental & Waste Services 82 70
Farming/Agriculture 31 63
Financial Svcs. (Non-bank & Insurance) 232 36
Food Processing 88 55
Food Wholesalers 17 43
Furn/Home Furnishings 35 17
Green & Renewable Energy 22 88
Healthcare Products 242 160
Healthcare Support Services 128 131
Heathcare Information and Technology 129 132
Homebuilding 32 64
Hospitals/Healthcare Facilities 36 145
Hotel/Gaming 65 171
Household Products 127 26
Information Services 69 283
Insurance (General) 19 693
Insurance (Life) 24 15
Insurance (Prop/Cas.) 51 71
Investments & Asset Management 192 120
Machinery 120 27
Metals & Mining 92 37
Office Equipment & Services 22 16
Oil/Gas (Integrated) 4 13
Oil/Gas (Production and Exploration) 269 19
Oil/Gas Distribution 24 606
Oilfield Svcs/Equip. 136 28
Packaging & Container 24 43
Paper/Forest Products 15 20
Power 52 28
Precious Metals 83 98
Publishing & Newspapers 31 28
R.E.I.T. 234 91
Real Estate (Development) 20 146
Real Estate (General/Diversified) 12 31
Real Estate (Operations & Services) 57 23
Recreation 63 50
Reinsurance 2 153
Restaurant/Dining 77 66
Retail (Automotive) 26 20
Retail (Building Supply) 17 202
Retail (Distributors) 80 28
Retail (General) 18 22
Retail (Grocery and Food) 13 38
Retail (Online) 70 319
Retail (Special Lines) 89 25
Rubber& Tires 4 15
Semiconductor 72 109
Semiconductor Equip 39 26
Shipbuilding & Marine 10 30
Shoe 11 27
Software (Entertainment) 86 60
Software (Internet) 30 90
Software (System & Application) 363 144
Steel 32 11
Telecom (Wireless) 18 27
Telecom. Equipment 91 66
Telecom. Services 67 115
Tobacco 17 33
Transportation 18 24
Transportation (Railroads) 8 20
Trucking 33 18
Utility (General) 16 26
Utility (Water) 17 46
Total Market 7053 61
Total Market (without financials) 5878 62

Updated: Jan 2020

Hot Stocks To Watch:

About Halozyme Therapeutics

Halozyme Therapeutics Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules a... HALO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT